Clinical studies indicate that female gender is associated with lower viral loads, higher CD4 counts, pronounced ART side effects, and a more rapid progression to AIDS, though this has not been shown in the Yunnan population [9,16,34–40]. The gene discussed is CD4; the disease is AIDS.